Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.18 AUD -2.7% Market Closed
Market Cap: 190.4m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Gross Margin
Arovella Therapeutics Ltd

100%
Current
-9%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
100%
=
Gross Profit
155.7k
/
Revenue
155.7k

Gross Margin Across Competitors

Country AU
Market Cap 189.1m AUD
Gross Margin
100%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 744.2B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 373.9B USD
Gross Margin
69%
Country US
Market Cap 258.4B USD
Gross Margin
77%
Country CH
Market Cap 200.6B CHF
Gross Margin
73%
Country UK
Market Cap 161.8B GBP
Gross Margin
82%
Country CH
Market Cap 180.7B CHF
Gross Margin
75%
Country US
Market Cap 146.9B USD
Gross Margin
71%
No Stocks Found

Arovella Therapeutics Ltd
Glance View

Market Cap
189.1m AUD
Industry
Pharmaceuticals

Arovella Therapeutics Ltd. develops pharmaceuticals and distributes medical devices and consumables. The company is headquartered in Perth, Western Australia. The company went IPO on 2002-01-24. The firm focuses on specific disease areas, oncology and conditions that affect the central nervous system. The company is focused on developing therapies to treat human disease. The firm is developing its invariant natural killer T (iNKT) cell therapy platform to treat blood cancers. The firm's OroMist technology develops oral sprays to reformulate pharmaceuticals. Its ZolpiMist oral spray formulation of zolpidem tartrate to treat short-term insomnia. The company is also developing oral sprays to treat migraine headaches, motion sickness, and drug-resistant epilepsy.

ALA Intrinsic Value
0.01 AUD
Overvaluation 96%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
100%
=
Gross Profit
155.7k
/
Revenue
155.7k
What is the Gross Margin of Arovella Therapeutics Ltd?

Based on Arovella Therapeutics Ltd's most recent financial statements, the company has Gross Margin of 100%.